“…A lifespan checkpoint at which several distinct traits of mitochondrial functionality and homeostasis are linked to an age-related “liponecrotic” form of PCD is called checkpoint 7; it exists in ST growth phase [ 19 , 20 , 210 , 211 ]. These traits include (1) the efficiency with which mitochondria generate energy needed for the detoxification of non-esterified fatty acids through their incorporation into neutral lipids; an age-related decline in such efficiency accelerates age-related liponecrotic PCD by causing the excessive accumulation of monounsaturated fatty acids in cellular membranes; (2) the efficiencies with which mitochondria produce and release ROS; an age-related rise in such efficiencies above a threshold accelerates age-related liponecrotic PCD by causing oxidative damage to cellular macromolecules and organelles; and (3) the efficiency with which aged and dysfunctional mitochondria undergo an Atg32- and Aup1-driven selective autophagic degradation; an age-related decline in such efficiency accelerates age-related liponecrotic PCD by impairing the maintenance of a healthy population of fully functional mitochondria [ 18 , 19 , 20 , 158 , 159 , 182 , 210 , 211 , 212 , 213 , 214 , 215 ] ( Figure 3 ).…”